Skip to main content
Back to Qiming Venture Partners

Qiming Venture Partners's Therapeutics Portfolio

Browse 26 Therapeutics companies funded by Qiming Venture Partners. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
26
Total Funding in Therapeutics
$2.0B

Therapeutics Portfolio Companies (26)

Export
MedicalOncologyTherapeutics

Sesame Therapeutics is a healthcare company that provides precision oncology medicines with therapeutic windows.

Plymouth, United States
July 2025
$19.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.

Berkeley, United States
July 2025
$54.5M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.

Amsterdam, The Netherlands
June 2026
$45.4M
Undisclosed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Vivatides Therapeutics develops RNA treatments to help improve patients' lives using biotechnology research.

Woburn, United States
April 2026
$54.0M
Series A

Founder Contacts

30,000+ verified contacts

MedicalTherapeutics

Neuro3 Therapeutics is a Hong Kong based company that advances medicines for CNS diseases.

Hong Kong, Hong Kong
March 2025
$3.5M
Seed

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.

Doylestown, United States
March 2026
$89.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyProduct ResearchTherapeutics

Candid Therapeutics develops therapies for autoimmune diseases using antibody-based technologies that modulate immune system activity.

San Diego, United States
March 2026
$505.0M
Undisclosed

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsPharmaceuticalTherapeutics

GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.

South San Francisco, United States
January 2024
$24.0M
Series A

Founder Contacts

30,000+ verified contacts

MedicalPharmaceuticalTherapeutics

Allorion Therapeutics is a small molecule therapeutic development company that focuses on cancer and autoimmune illnesses.

Natick, United States
March 2023
$50.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaHealth CareMedicalTherapeutics

Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.

Woburn, United States
December 2025
$110.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsMedicalmHealthTherapeutics

Caidya is a clinical research organization that provides personalized solutions for various therapeutic areas.

Raleigh, United States
January 2025
$165.0M
Private Equity

Founder Contacts

30,000+ verified contacts

Health CareHealth DiagnosticsLife ScienceTherapeutics

Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders

South San Francisco, United States
October 2022
$12.2M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

MedicalPharmaceuticalTherapeutics

Ruining Bio provides clinical medical solutions such as tumor radiotherapy protection and wound repair.

Jiading, China
February 2026
$14.6M
Series C

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiopharmaBiotechnologyGeneticsNanotechnologyPharmaceuticalTherapeutics

BreezeBio is a biotechnology business that creates genetic therapies using precision, non-viral delivery across clinically important tissues

Brisbane, United States
February 2026
$60.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalOncologyPharmaceuticalTherapeutics

Vybio is a high-tech enterprise focusing on innovative drug research and development.

Hangzhou, China
November 2025
$14.1M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalTherapeutics

Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the regulation of epigenetic mechanisms.

Shanghai, China
September 2025
$60.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceuticalProduct ResearchTherapeutics

Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.

Shanghai, China
August 2025
$131.0M
Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth DiagnosticsTherapeutics

Simaixu Biotechnology is a biopharmaceutical firm that develop small molecule drugs for cancer, and chronic diseases with new technologies

Suzhou, China
July 2025
$1.6M
Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.

Newton, United States
July 2025
Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyPharmaceuticalProduct ResearchTherapeutics

Novamab focuses on the research and development of new nanobodies.

Shanghai, China
July 2024
$24.4M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaHealth CareTherapeutics

Alpha Biophama is a clinical stage biopharmaceutical company.

Huangpu, China
June 2024
$23.9M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsTherapeutics

Tourmaline Bio is a biotechnology company that develops medicines to treat inflammatory and immune diseases in patients.

New York, United States
January 2024
$172.5M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsTherapeutics

Medilink Therapeutics is a biotech company focusing on next-generation antibody-drug conjugate Research & development.

Suzhou, China
March 2022
$70.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Abogen Biosciences is a clinical stage biotechnology company focuses on developing nucleic acid-based RNA therapeutics.

Suzhou, China
November 2021
$300.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsLife ScienceTherapeutics

Basecamp Bio develops cell and gene therapies, regenerative medicine, and immunotherapies.

Waltham, United States
March 2021
$14.0M
Angel

Founder Contacts

30,000+ verified contacts

Health CareMedicalMedical DeviceSalesTherapeutics

DiNovA Medtech develops vascular intervention technology for the treatment of aneurysm.

Hangzhou, China
April 2020
$17.0M
Series C

Founder Contacts

30,000+ verified contacts

Explore Qiming Venture Partners's Full Portfolio

View all companies funded by Qiming Venture Partners across every industry and funding stage.

View Full Qiming Venture Partners Portfolio